Welcome to Business Insiders daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.

Pills 2 (2)
Hollis Johnson/Business Insider

Hello,

Today in healthcare news: GoodRx is making its stock-market debut after pricing shares at $33 apiece just after midnight. At that price, the company is valued at $12.7 billion. What a time to be in the digital health/online prescription drug coupon business. 

Also: Johnson & Johnson has started a 60,000-person coronavirus vaccine trial, coronavirus deaths passed 200,000, and your ultimate guide to reading through vaccine data

Speaking of vaccines (and when are we not!):  Our biotech reporter Andrew Dunn is moderating a conversation on October 5 at 2 p.m. ET on the coronavirus vaccine race with 3 top experts:

  • Maria Elena Bottazzi, co-director of Texas Children's Hospital Center for Vaccine Development
  • Art Caplan, bioethicist and founding head of the Division of Medical Ethics at New York University School of Medicine
  • Dr. William Haseltine, infectious-disease expert and chair and president of ACCESS Health International

Sign up here to attend!


vaccine
Steve Parsons-WPA Pool/Getty Images

Pharma giant J&J just launched a pivotal 60,000-person coronavirus vaccine trial, and we could learn if the shot works by the end of 2020

Read the full story from Andrew Dunn here>>


Coronavirus
Medical personnel move a deceased patient to a refrigerated truck serving as make shift morgues at Brooklyn Hospital Center on April 09, 2020 in New York City. -
ANGELA WEISS/AFP via Getty Images

The coronavirus has killed at least 200,000 people in the United States, another grim milestone for the pandemic

Read the full story from Yelena Dzhanova here>>


Trump NIH NIAID coronavirus vaccine
Deputy Director at the Vaccine Research Center at the National Institutes of Health, Dr. Barney Graham, speaks with President Donald Trump during a tour of the Viral Pathogenesis Laboratory at the National Institutes of Health, Tuesday, March 3, 2020, in Bethesda, Md.
Evan Vucci/Associated Press

5 experts lay out how they'll determine whether a coronavirus vaccine is really safe and effective — here's what to know to evaluate the data for yourself

Read the full story from Andrew Dunn here>> 


More stories we're reading:


Be sure to sign up for our newsletter here if you haven't already!

- Lydia

Read the original article on Business Insider